Case Report
Accepted on 03 Apr 2026
BKV-Specific T Cells: A fast, safe and potentially effective treatment option for refractory BKV Infections in Pediatric Patients After Allogeneic Stem Cell Transplantation
in Pediatric Hematology and Hematological Malignancies